Haviland Kate's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Apr 3, 2025
- Accession no.
- 0001415889-25-009959
- Filed
- Apr 3, 2025
- Trade date
- Apr 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $216.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Haviland KateCIK 0001663022 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Common Stock | SSaleDisposed | −600 | $85.47 | −$51,282 | 167,827 | Direct | |
| Apr 1, 2025 | Common Stock | SSaleDisposed | −598 | $86.14 | −$51,511.72 | 167,229 | Direct | |
| Apr 1, 2025 | Common Stock | SSaleDisposed | −1,200 | $87.34 | −$104,808 | 166,029 | Direct | |
| Apr 1, 2025 | Common Stock | SSaleDisposed | −100 | $88.59 | −$8,859 | 165,929 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.